NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 324 filers reported holding NATERA INC in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $281,000 | -17.4% | 3,012 | -1.2% | 0.04% | -9.3% |
| Q3 2021 | $340,000 | -1.7% | 3,050 | -0.0% | 0.04% | -12.2% |
| Q2 2021 | $346,000 | -96.9% | 3,051 | -97.2% | 0.05% | -97.0% |
| Q1 2021 | $11,199,000 | +4.3% | 110,290 | +2.2% | 1.62% | -6.8% |
| Q4 2020 | $10,741,000 | +101.6% | 107,926 | +46.3% | 1.73% | +55.4% |
| Q3 2020 | $5,329,000 | +81.1% | 73,763 | +25.0% | 1.12% | +78.1% |
| Q2 2020 | $2,942,000 | +95.7% | 59,002 | +17.2% | 0.63% | +37.9% |
| Q1 2020 | $1,503,000 | -11.5% | 50,343 | -0.1% | 0.45% | +30.1% |
| Q4 2019 | $1,698,000 | +3.6% | 50,412 | +0.9% | 0.35% | -20.0% |
| Q3 2019 | $1,639,000 | +17.7% | 49,965 | -1.0% | 0.44% | +22.5% |
| Q2 2019 | $1,393,000 | +56.3% | 50,491 | +16.9% | 0.36% | +42.4% |
| Q1 2019 | $891,000 | – | 43,205 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |